James Rothman

James Rothman is among the most distinguished medical scientists of our time. He was awarded the 2013 Nobel Prize in Physiology or Medicine for his groundbreaking work explaining how cells transport materials inside themselves.

‍

James speaks on the future of science. He will take you on a tour of scientific and medical breakthroughs, explaining how progress in the lab translates into developments that transform the world we live in. In particular, he lays out the striking changes that will shape health and wellbeing in society over the years to come.

‍

The Nobel is only one in a long line of awards, which include a Royal Society Fellow (2019), the King Faisal International Prize for Science (1996), the Gairdner Foundation International Award (1996), the Lounsbery Award of the National Academy of Sciences (1997), the Heineken Foundation Prize of the Netherlands Academy of Sciences (2000), the Louisa Gross Horwitz prize of Columbia University (2002), the Lasker Basic Science Award (2002), and the Kavli Prize for Neuroscience (2010). James is a member of the National Academy of Sciences and its Institute of Medicine, and a Fellow of the American Academy of Arts and Sciences.

‍

Rothman is the Fergus F. Wallace Professor of Biomedical Sciences at Yale University. He was recently appointed Sterling Professor of Cell Biology at Yale School of Medicine. Rothman is Chairman of the Department of Cell Biology and is also the Director of the Nanobiology Institute at the Yale West Campus. He also serves as Adjunct Professor of Physiology and Cellular Biophysics at Columbia University and a research professor at University College, London. Over the course of his long career, James has served as E.R. Squibb Professorship of Molecular Biology at Princeton University, and founding chairman of the Department of Cellular Biochemistry and Biophysics at Memorial Sloan-Kettering Cancer Center, where he held the Paul A. Marks Chair and served as Vice-Chairman. Prior to coming to Yale in 2008, Dr. Rothman was the Wu Professor of Chemical Biology in the Department of Physiology and Cellular Biophysics, and Director of Columbia University’s Sulzberger Genome Center.

‍

Dr. Rothman served extensively in industry. Currently, he is the Senior Scientific Advisor for Biomedical Research at GE’s Global Research Center, and from 2003-2007 was the Chief Scientific Advisor of GE Healthcare. At various times he served on or chaired senior Scientific Advisory Boards of ARIAD Pharmaceuticals, GSK, Johnson & Johnson, Eli Lilly, and Merck, and has advised Genentech and Biogen. He also advises a New York-based private equity fund, Arsenal Capital Partners.

‍

He is a 2014 recipient of the French Legion of Honor in recognition of his scientific achievements.

‍